Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shot up 4% during trading on Monday . The stock traded as high as $119.00 and last traded at $117.99. 365,144 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 2,548,667 shares. The stock had previously closed at $113.44.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 1.3 %
The firm’s 50 day simple moving average is $106.88 and its 200 day simple moving average is $118.31.
Institutional Trading of Direxion Daily S&P Biotech Bull 3x Shares
Hedge funds have recently bought and sold shares of the stock. Traynor Capital Management Inc. bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter worth about $325,000. Gateway Advisory LLC bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter worth about $366,000. Sheaff Brock Investment Advisors LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at about $488,000. Jump Financial LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at about $521,000. Finally, McGuire Investment Group LLC grew its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 11.4% during the 1st quarter. McGuire Investment Group LLC now owns 4,594 shares of the company’s stock valued at $610,000 after purchasing an additional 470 shares during the last quarter.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- How to Calculate Retirement Income: MarketBeat’s Calculator
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.